Rosavin

Rosavin is a phenylpropanoid glycoside derived from Rhodiola rosea that acts as a potent antioxidant by inhibiting reactive oxygen species formation. This bioactive compound demonstrates lipid-lowering effects and analgesic properties through its modulation of oxidative stress pathways.

Origin & History

Rosavin is a phenylpropanol compound primarily found in the rhizomes of the perennial herb Rhodiola rosea L., also known as Golden Root or Arctic Root. It is extracted using methods like high-performance liquid chromatography (HPLC) and is known for its rose-like aroma.

Historical & Cultural Context

Rhodiola rosea L., the source of Rosavin, has been used in traditional medicine, particularly noted for its antifatigue and antistress effects observed by Russian botanists. These traditional uses highlight its value in herbal medicine practices.

Health Benefits

• Antioxidant activity: Rosavin inhibits reactive oxygen species, providing significant antioxidant effects in preclinical models.[1] • Lipid-lowering effects: Studies demonstrate its potential to lower lipid levels in animal models, suggesting benefits for cardiovascular health.[1] • Analgesic properties: In vitro and in vivo studies show Rosavin's ability to reduce pain perception.[1][2] • Antitumor activity: Preclinical research indicates Rosavin may inhibit tumor growth, though human studies are lacking.[1] • Immunomodulatory effects: Evidence from animal studies points to Rosavin's potential to modulate immune responses.[1]

How It Works

Rosavin exerts its antioxidant effects by scavenging reactive oxygen species (ROS) and inhibiting lipid peroxidation through modulation of antioxidant enzyme systems including superoxide dismutase and catalase. The compound influences lipid metabolism by regulating HMG-CoA reductase activity and enhancing cholesterol excretion pathways. Its analgesic properties appear to involve modulation of inflammatory mediators and nociceptive pathways.

Scientific Research

No specific human clinical trials or meta-analyses for Rosavin are available. The evidence is limited to in vitro and in vivo studies demonstrating various pharmacological effects.[1][2]

Clinical Summary

Current evidence for rosavin is primarily limited to preclinical animal studies and in vitro research. Animal studies have demonstrated significant antioxidant activity with measurable reductions in oxidative stress markers. Lipid-lowering effects have been observed in rodent models with reported decreases in total cholesterol and triglyceride levels. Human clinical trials specifically investigating isolated rosavin are lacking, limiting the strength of evidence for therapeutic applications in humans.

Nutritional Profile

Rosavin is a phenylpropanoid glycoside compound (molecular formula C20H28O10, molecular weight 428.43 g/mol), not a whole food ingredient and therefore does not contain conventional macronutrients, micronutrients, fiber, or protein. As a pure bioactive compound, its profile is defined entirely by its chemical structure and pharmacological activity. Rosavin is one of the primary marker compounds found in Rhodiola rosea root, where it occurs at concentrations of approximately 0.8–3% by dry weight in standardized extracts, with commercial extracts typically standardized to a minimum of 3% rosavin content. It belongs to the cinnamyl alcohol glycoside subclass, consisting of a cinnamyl alcohol aglycone linked to a trisaccharide unit (glucose, arabinose, and rhamnose). Structurally related compounds present alongside rosavin in its natural source include rosin and rosarin, which share the same glycoside backbone but differ in sugar moiety composition. Bioavailability data is limited in humans; preclinical studies suggest rosavin undergoes hydrolysis in the gastrointestinal tract, releasing the cinnamyl alcohol aglycone, which is believed to be the primary bioactive moiety absorbed. Oral bioavailability is considered moderate, with enzymatic degradation by gut microbiota potentially influencing active metabolite availability. No caloric, vitamin, or mineral content is attributable to rosavin as an isolated compound.

Preparation & Dosage

There are no clinically studied dosage ranges or forms for Rosavin due to the absence of human trials. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Salidroside, Tyrosol, Flavonoids, Tannins

Safety & Interactions

Safety data for isolated rosavin is limited, with most information derived from Rhodiola rosea studies containing multiple active compounds. No major adverse effects have been reported in preclinical studies at standard dosages. Potential interactions with cardiovascular medications and blood thinners should be considered due to its lipid-lowering and antioxidant properties. Pregnant and breastfeeding women should avoid use due to insufficient safety data.